...
search icon
oabi-img

OmniAb Inc. Share Price

OABI
NMQ
$1.7
+$0.01
(0.59%)
1D
Industry: Biotechnology Sector: Health Care

OmniAb Inc. Analyst Forecast

OmniAb Inc. Share Price Chart

OmniAb Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$243.28M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
354.50K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.85
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.22 L
$4.02 H
$1.7

About OmniAb Inc., Common Stock

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. more

Industry: BiotechnologySector: Health Care

OmniAb Inc. Stock Returns

Time FrameOABISectorS&P500
1-Week Return--1.08%-1.38%
1-Month Return-10.53%-0.47%-1.81%
3-Month Return11.84%2.13%1.38%
6-Month Return-17.07%17.04%5.68%
1-Year Return-53.3%6.56%11.74%
3-Year Return-55.44%16.78%65.15%
5-Year Return-82.58%34.34%73.68%

OmniAb Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue23.27M34.75M59.08M34.16M26.39M[{"date":"2020-12-31","value":39.39,"profit":true},{"date":"2021-12-31","value":58.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.83,"profit":true},{"date":"2024-12-31","value":44.67,"profit":true}]
Cost of Revenue-14.97M16.25M19.50M19.68M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":76.05,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":99.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit23.27M34.75M59.08M34.16M26.39M[{"date":"2020-12-31","value":39.39,"profit":true},{"date":"2021-12-31","value":58.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.83,"profit":true},{"date":"2024-12-31","value":44.67,"profit":true}]
Gross Margin100.00%100.00%100.00%100.00%100.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses48.89M70.36M85.72M103.58M100.89M[{"date":"2020-12-31","value":47.2,"profit":true},{"date":"2021-12-31","value":67.92,"profit":true},{"date":"2022-12-31","value":82.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.4,"profit":true}]
Operating Income(25.62M)(35.61M)(26.65M)(69.42M)(74.50M)[{"date":"2020-12-31","value":-2562300000,"profit":false},{"date":"2021-12-31","value":-3560900000,"profit":false},{"date":"2022-12-31","value":-2664800000,"profit":false},{"date":"2023-12-31","value":-6941900000,"profit":false},{"date":"2024-12-31","value":-7450200000,"profit":false}]
Total Non-Operating Income/Expense1.89M1.25M1.17M9.52M6.20M[{"date":"2020-12-31","value":19.86,"profit":true},{"date":"2021-12-31","value":13.16,"profit":true},{"date":"2022-12-31","value":12.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.12,"profit":true}]
Pre-Tax Income(23.73M)(34.35M)(26.06M)(64.36M)(71.41M)[{"date":"2020-12-31","value":-2372800000,"profit":false},{"date":"2021-12-31","value":-3435000000,"profit":false},{"date":"2022-12-31","value":-2606100000,"profit":false},{"date":"2023-12-31","value":-6436300000,"profit":false},{"date":"2024-12-31","value":-7141100000,"profit":false}]
Income Taxes(6.17M)(7.31M)(3.73M)(13.74M)(9.38M)[{"date":"2020-12-31","value":-617100000,"profit":false},{"date":"2021-12-31","value":-730800000,"profit":false},{"date":"2022-12-31","value":-372700000,"profit":false},{"date":"2023-12-31","value":-1374400000,"profit":false},{"date":"2024-12-31","value":-937800000,"profit":false}]
Income After Taxes(17.56M)(27.04M)(22.33M)(50.62M)(62.03M)[{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false},{"date":"2024-12-31","value":-6203300000,"profit":false}]
Income From Continuous Operations(17.56M)(27.04M)(22.33M)(29.75M)(62.03M)[{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-2974600000,"profit":false},{"date":"2024-12-31","value":-6203300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(17.56M)(27.04M)(22.33M)(50.62M)(62.03M)[{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false},{"date":"2024-12-31","value":-6203300000,"profit":false}]
EPS (Diluted)-(0.02)(0.24)(0.53)(0.60)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2,"profit":false},{"date":"2022-12-31","value":-24,"profit":false},{"date":"2023-12-31","value":-53,"profit":false},{"date":"2024-12-31","value":-60,"profit":false}]

OmniAb Inc. Ratios

OmniAb Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

OABI
Cash Ratio 4.48
Current Ratio 5.00
Quick Ratio 4.96

OmniAb Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OABI
ROA (LTM) -12.69%
ROE (LTM) -22.37%

OmniAb Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OABI
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

OmniAb Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OABI
Trailing PE NM
Forward PE NM
P/S (TTM) 11.53
P/B 0.88
Price/FCF NM
EV/R 9.81
EV/Ebitda NM

FAQs

What is OmniAb Inc. share price today?

OmniAb Inc. (OABI) share price today is $1.7

Can Indians buy OmniAb Inc. shares?

Yes, Indians can buy shares of OmniAb Inc. (OABI) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OABI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of OmniAb Inc. be purchased?

Yes, you can purchase fractional shares of OmniAb Inc. (OABI) via the Vested app. You can start investing in OmniAb Inc. (OABI) with a minimum investment of $1.

How to invest in OmniAb Inc. shares from India?

You can invest in shares of OmniAb Inc. (OABI) via Vested in three simple steps:

  • Click on Sign Up or Invest in OABI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in OmniAb Inc. shares
What is OmniAb Inc. 52-week high and low stock price?

The 52-week high price of OmniAb Inc. (OABI) is $4.02. The 52-week low price of OmniAb Inc. (OABI) is $1.22.

What is OmniAb Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of OmniAb Inc. (OABI) is

What is OmniAb Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of OmniAb Inc. (OABI) is 0.88

What is OmniAb Inc. dividend yield?

The dividend yield of OmniAb Inc. (OABI) is 0.00%

What is the Market Cap of OmniAb Inc.?

The market capitalization of OmniAb Inc. (OABI) is $243.28M

What is OmniAb Inc.'s stock symbol?

The stock symbol (or ticker) of OmniAb Inc. is OABI

How Can Investors Use OmniAb Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of OmniAb Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether OmniAb Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from OmniAb Inc. shares for Indian investors?

When investing in OmniAb Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the OmniAb Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare OmniAb Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of OmniAb Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that OmniAb Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top